Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-02-05
1983-11-15
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31505
Patent
active
044155751
ABSTRACT:
Heterocyclic carbamates are disclosed which have potent gastric secretion inhibitory properties. The heterocyclic substituent is a pyridyl group or a 6-membered heterocycle with two nitrogen heteroatoms, which may be optionally substituted. Further substituents on the carbamate nitrogen and oxygen atoms are also disclosed. The compounds have profound effects on the inhibition of gastric secretions in the gastro-intestinal tract, and compositions for such uses are also disclosed.
REFERENCES:
patent: 4008235 (1977-02-01), Lesher et al.
patent: 4144338 (1979-03-01), Bolhofer
Bolhofer William A.
Prugh John D.
Coughlan, Jr. Paul M.
Lopez Gabriel
Merck & Co. , Inc.
Mitri Salvatore C.
Pfeiffer Hesna J.
LandOfFree
Suppression of gastric acid secretion using pyrimidylcarbamates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppression of gastric acid secretion using pyrimidylcarbamates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of gastric acid secretion using pyrimidylcarbamates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-159461